Clinical trials
Phase 2 Obesity trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2013 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Novo Nordisk A/S | 2 |
| Alizyme | 1 |
| Danisco | 1 |
| Marjukka Kolehmainen | 1 |
| Sanofi | 1 |
| Solvay Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 9 |
| Nutrition Disorders | 3 |
| Overweight | 3 |
| Body Weight | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Metabolic Diseases | 2 |
| Nutritional and Metabolic Diseases | 2 |
| Atherosclerosis | 1 |
| Endotoxemia | 1 |
| Glucose Intolerance | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.